Evaluation of ceftazidime in the treatment of severe infection.
Ten seriously ill patients with infections caused by multiply-resistant organisms were treated with intravenous ceftazidime. Nine showed clinical and bacteriological improvement. Apart from one patient who developed a mild transienterythematous rash, no side effects or toxicity was found.
Istituto di Anestesiologia e Rianimazione dell'Università degli Studi di Parma, Italy.
P
P
Zuccoli
I
I
Ho
M
M
Mergoni
L
L
Melley
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002442:Ceftazidime / Q000627:therapeutic use*; D005260:Female; D006413:Hematopoietic System / Q000187:drug effects; D006801:Humans; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D002442:Ceftazidime